CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $5.90 million as of 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-02-18
- 2025-12-27: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $5.90M.
- 2024-12-28: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $14.40M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2025-12-27 | $5.90M 10-K · filed 2026-02-18 |
| 2024-12-28 | $14.40M 10-K · filed 2025-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |